Showing results (1311-1320 of 2,692) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|June 30, 2022
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trialMark F Cotton, Shabir A Madhi, Angelique K Luabeya, et al.
The Lancet. Infectious Diseases|October 22, 2022
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trialSaye H Khoo, Richard FitzGerald, Geoffrey Saunders, et al.
The Lancet. Infectious Diseases|October 27, 2019
Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing studyMichaela J Day, Katie L Hopkins, David W Wareham, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
The Lancet. Infectious Diseases|December 15, 2022
Effects of social norm feedback on antibiotic prescribing and its characteristics in behaviour change techniques: a mixed-methods systematic reviewYingchao Zeng, Lin Shi, Chaojie Liu, et al.
The Lancet. Infectious Diseases|June 3, 2004
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosisMonique A S H Mennink-Kersten, J Peter Donnelly, Paul E Verweij
The Lancet. Infectious Diseases|April 15, 2011
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreakFrançois Caron, Isabelle Parent du Châtelet, Jean-Philippe Leroy, et al.
The Lancet. Infectious Diseases|June 25, 2011
Consequences of HIV infection on malaria and therapeutic implications: a systematic reviewClara Flateau, Guillaume Le Loup, Gilles Pialoux
The Lancet. Infectious Diseases|October 30, 2012
Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trialRovina Ruslami, A Rizal Ganiem, Sofiati Dian, et al.
The Lancet. Infectious Diseases|July 24, 2012
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance dataRyan T Novak, Jean Ludovic Kambou, Fabien Vk Diomandé, et al.
Pageof 270